Dihydrotachysterol: a bad choice in the treatment of chronic hypoparathyroidism
Hypoparathyroidism is an endocrine disease caused by damage of the parathyroid glands and characterized by underproduction of parathyroid hormone. This can lead to severe hypocalcemia and its associated complications. The chronic hypoparathyroidism requires lifelong therapy including calcium and vit...
Main Authors: | E. S. Avsievich, E. V. Kovaleva, A. M. Gorbacheva, A. K. Eremkina, N. G. Mokrysheva |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2022-09-01
|
Series: | Ожирение и метаболизм |
Subjects: | |
Online Access: | https://www.omet-endojournals.ru/jour/article/view/12882 |
Similar Items
-
Hypoparathyroidism
by: N S Kuznetsov, et al.
Published: (2012-09-01) -
Hypoparathyroidism: disease update
by: Natalia Mokrysheva, et al.
Published: (2016-01-01) -
Hypoparathyroidism: update of guidelines from the 2022 International Task Force
by: Bart L. Clarke
Published: (2022-12-01) -
Hypoparathyroidism: Basis for the approach and appropiate treatment
by: Roman-Gonzalez, Alejandro, et al.
Published: (2018-04-01) -
Postoperative Hypoparathyroidism and the Viability of the Parathyroid Glands During Thyroidectomy
by: Yong Bae Ji, et al.
Published: (2017-09-01)